Peptide therapy on TikTok: separating signal from hype

What did @drsarawhatley actually say?

Dr. Sarah Watley, identifying herself as being with Stacked Peptides, made a sourcing and safety pitch. She said the company sources from a supplier called AlphaBioMet, that orders come with a "full COA and liability coverage," and that "safety comes first." She didn't make any specific therapeutic claims about peptides in this clip. The entire video was essentially a vendor endorsement framed around quality control. That framing is worth examining carefully, because the words sound reassuring but the regulatory picture is more complicated than she let on.

To her credit, she acknowledged that the peptide space is largely unregulated. That part is accurate. But saying you have a COA and a reliable source is not the same as saying your peptides are legal, tested to pharmaceutical standards, or approved for human use.

Does the science back this up?

There is no published peer-reviewed research that specifically validates AlphaBioMet as a supplier, and no regulatory body certifies peptide research chemical suppliers for human-use safety. A COA from a third-party lab confirms chemical identity and purity at a point in time. It does not confirm sterility, endotoxin levels, or long-term stability.

Research on compounded and unregulated peptides has found real contamination risks. A 2020 analysis published in Drug Testing and Analysis (Eichner et al., 2020) found that several peptide products sold online contained incorrect sequences, degradation products, or unlisted additives. The COA model provides one layer of quality assurance, but it is not a substitute for FDA oversight, current Good Manufacturing Practice (cGMP) compliance, or clinical-grade sterility testing. The liability coverage she mentioned is a legal instrument, not a pharmacological safety guarantee. These are very different things, and conflating them does a disservice to consumers trying to make informed decisions.

What did they get wrong (or right)?

She got the broad warning right. The peptide market is genuinely unregulated, and sourcing does matter. Studies have confirmed product inconsistency across vendors. That is a real problem she is pointing to, even if her solution is self-serving.

What she got wrong, or at least incomplete, is the implication that a COA plus a named supplier equals safety. COAs vary widely in scope. Some test only for the target compound; others test for heavy metals, bacterial endotoxins, and residual solvents. She gave no information about what AlphaBioMet's COAs actually cover. "Liability coverage" is also a vague term that could mean anything from an insurance policy to a basic indemnification clause. Neither tells you whether the peptide you are injecting is actually sterile. And most peptides sold through platforms like Stacked Peptides are sold as research chemicals, not as drugs, meaning the company is not legally authorized to sell them for human use regardless of how clean the COA looks.

What should you actually know?

If you are considering peptide therapy, the sourcing conversation is the right one to have, but it needs to go deeper than a supplier name and a document. Here is what actually matters: whether the compound was manufactured under cGMP conditions, whether sterility testing was performed on the final vial, whether endotoxin testing was done, and whether the prescribing provider is operating within a licensed compounding pharmacy framework regulated by state boards of pharmacy and, where applicable, the FDA.

In the United States, peptides like BPC-157, TB-500, and others have been placed on the FDA's list of bulk drug substances that cannot be used in compounding, depending on the year and regulatory update. The legal status of many of these compounds is actively shifting. A COA does not change a peptide's regulatory classification. Working with a telehealth provider that sources through a licensed 503A or 503B compounding pharmacy provides a meaningfully different level of oversight than purchasing from a vendor that supplies "research chemicals." The difference is not semantic. It affects your safety and your legal exposure as a consumer.